Would you like to broaden your knowledge on biomarker development and validation? SMEs from Europe have the exceptional opportunity to apply for the interactive online seminar on biomarker validation topics hosted by IBBL (Integrated BioBank of Luxembourg) until November 25, 2022. The participation fees for the workshop are covered by the Interreg NWE Codex4SMEs project. Date: 28 November 2022 | 9:30 – 13:45 CET (Amsterdam, Berlin, Paris).
Apply for this unique online seminar to learn about the importance of pre-analytics in biomarker discovery and the benefits of biomarker validation. The online seminar is offered by Integrated Biobank Luxembourg and targets SMEs from North-West Europe and other European regions that develop biomarkers for diagnostics. The interactive online seminar is divided into two parts.
In part I, experts from BBMRI.be, Strategiqual and IBBL will present strategies for biomarker validation in three lectures. You will also learn first-hand from SMEs about successful biomarker commercialisations.
In part II, you will have the opportunity to arrange individual 30 minute 1:1 meetings with our experts from BBMRI.be and Strategiqual. Please contact the respective experts after successful registration. If you want to receive tailored coaching for strategic biomarker development from IBBL experts, please apply for a Consultancy Service on specific biomarker topics.
|9:30 – 9:45||Welcome and introduction of Codex4SMEs projectSpeaker: Monica Marchese, PhD, Translational Biomarker Group Leader IBBL (Integrated BioBank of Luxembourg)|
|9:45 – 10:15||The importance of biobank networks for SME’sSpeaker: Annelies Debucquoy, National Node Director BBMRI.be, Belgian Cancer Registry, Belgium An introduction to biobank networks, services and opportunities for collaboration with the largest European biobank infrastructure BBMRI-ERIC from the perspective of the National biobank network in Belgium (BBMRI.be), access to samples and data, support and guidance on topics related to ethical/legal aspects of biobanking and how to assure the highest quality of samples.|
|10:15 – 10:45||Collaboration with SME’s from a hospital integrated biobank point of viewSpeaker: Elke Smits, Chief Science & Innovation Officer, University Hospital Antwerp & President BBMRI.be, Belgium This session, will bring some hands-on examples of collaborations between SME’s and biobanks from a hospital integrated biobank point of view. Experiences in merging translational and clinical research within clinical practice both in an academic as industrial setting as well as how to get the best out of collaborations between SME’s and biobanks will be shared.|
|10:45 – 11:15||Biomarker Validation: a critical step for successful Personalised MedicineSpeaker: Monica Marchese, PhD, Translational Biomarker Group Leader IBBL (Integrated BioBank of Luxembourg)|
|11:15 – 11:30||Coffee Break|
|11:30 – 12:30||Regulatory aspects – Global picture of the IVDR and roadmap for SMEsSpeaker: tbc,Strategiqual|
|12:30 – 12:45||Coffee Break|
|12:45 – 13:15||Translation of biomarker into marketBest practice examples of successful SMEs|
|13:15 – 13:45||Q&A session|
Note: The online training is limited to ten SMEs. The selection is made on a first-come, first-served basis. The training will only be carried out after three SMEs have registered for it.
Note: Our services are in general open to SMEs from all over North-West Europe with preference given to SMEs from one of the participating partner regions (see table of partners) for the services offered.
Discover more about BioRegio STERN Management GmbH:
Based in southwest Germany, BioRegio STERN Management GmbH acts as a business development agency for the regional biotech and life science sector. The primary goal is to anchor the BioRegion STERN and their business throughout Germany and internationally on a high level. An important strategy for the development of the regional cluster is to build on existing strengths. The regions Stuttgart and Tübingen are characterised by a prominent network of biotechnology and medical technology SMEs as well as universities & research institutes and including service provider companies.